Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies. The fund seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Industry, Sector and Symbol
Industry Personal credit institutions
Sub-IndustryAsset Management & Custody Banks
SectorFinance
Phone213-830-6300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$138.72 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/8/2019 (Confirmed)
OptionableOptionable
Oaktree Specialty Lending (NASDAQ:OCSL) Frequently Asked Questions
What is Oaktree Specialty Lending's stock symbol?
Oaktree Specialty Lending trades on the NASDAQ under the ticker symbol "OCSL."
How often does Oaktree Specialty Lending pay dividends? What is the dividend yield for Oaktree Specialty Lending?
Oaktree Specialty Lending declared a quarterly dividend on Friday, February 8th. Stockholders of record on Friday, March 15th will be paid a dividend of $0.095 per share on Friday, March 29th. This represents a $0.38 dividend on an annualized basis and a dividend yield of 7.28%. The ex-dividend date is Thursday, March 14th. View Oaktree Specialty Lending's Dividend History.
How were Oaktree Specialty Lending's earnings last quarter?
Oaktree Specialty Lending Corp (NASDAQ:OCSL) posted its earnings results on Thursday, February, 7th. The credit services provider reported $0.12 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.11 by $0.01. The credit services provider had revenue of $38.28 million for the quarter, compared to analysts' expectations of $36.80 million. Oaktree Specialty Lending had a net margin of 73.31% and a return on equity of 7.54%. View Oaktree Specialty Lending's Earnings History.
When is Oaktree Specialty Lending's next earnings date?
What price target have analysts set for OCSL?
5 brokers have issued 12-month target prices for Oaktree Specialty Lending's shares. Their forecasts range from $5.00 to $7.00. On average, they anticipate Oaktree Specialty Lending's share price to reach $5.85 in the next year. This suggests a possible upside of 12.1% from the stock's current price. View Analyst Price Targets for Oaktree Specialty Lending.
What is the consensus analysts' recommendation for Oaktree Specialty Lending?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oaktree Specialty Lending in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Oaktree Specialty Lending.
What are Wall Street analysts saying about Oaktree Specialty Lending stock?
Here are some recent quotes from research analysts about Oaktree Specialty Lending stock:
- 1. According to Zacks Investment Research, "Oaktree Specialty Lending Corporation is a specialty finance company. It provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company generates current income and capital appreciation by providing companies with flexible and innovative financing solutions including first and second lien loans, unsecured and mezzanine loans and preferred equity. Oaktree Specialty Lending Corporation, formerly known as Fifth Street Finance Corp., is based in CA, United States. " (4/13/2019)
- 2. National Securities analysts commented, " OCSL earned NII/share of $0.12 for F1Q19, a penny ahead of our estimate and comfortably above the $0.095/share quarterly dividend. Much more significant than the earnings beat, in our opinion, was that NAV/share improved to $6.19 from $6.09 Q/Q. Non-accruals (including PIK) appreciated by $47.1mm Q/Q.
The company has made excellent progress with not only rotating out of legacy Fifth Street assets, but it has done so at or above marks. This gives us a high degree of confidence in management’s ability to accurately assess conditions at portfolio companies and value them accordingly.
Subsequent to quarter-end, Maverick Healthcare was sold for a mark $12mm above the 12/31/18 marks. This leads us to model a sizable realized gain, although some of the gain will be held in escrow and likely realized in the 6/30/19 quarter, by our estimates. Dominion Diagnostics is also likely to be sold, although a timeframe was not given.
The success in the disposition of troubled, inherited assets speaks to the strength of Oaktree’s broader platform, particularly the restructuring group. We think that unlike most peers who brag about using the larger external manager, Oaktree has actually done this and will likely continue to do this in order to monetize remaining non-core investments.
The recycling of non-income producing equity and non-accrual assets as well as increased allocation to Kemper (which is only leveraged at about 1.00x at quarter-end with the ability to go to 2.00x) likely bodes well for effective yield and thus earnings despite higher yielding legacy investments largely rolling off.
We are revising our fiscal 2019 NII/share estimate to $0.50 from $0.45 and our fiscal 2020 NII/share estimate to $0.55 from $0.47. We are accordingly upgrading shares to BUY from NEUTRAL and increasing our price target to $7 from $5. " (2/7/2019)
Has Oaktree Specialty Lending been receiving favorable news coverage?
Press coverage about OCSL stock has trended positive recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Oaktree Specialty Lending earned a news impact score of 2.7 on InfoTrie's scale. They also gave media coverage about the credit services provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term.
Who are some of Oaktree Specialty Lending's key competitors?
What other stocks do shareholders of Oaktree Specialty Lending own?
Who are Oaktree Specialty Lending's key executives?
Oaktree Specialty Lending's management team includes the folowing people:
- Mr. Sandeep Kumar Khorana, Managing Director of Origination (Age 46)
- Mr. Edgar Lee, Chief Exec. Officer & Chief Investment Officer (Age 43)
- Mr. Mel Carlisle CPA, Chief Financial Officer & Treasurer (Age 50)
- Mr. Mathew M. Pendo, Chief Operating Officer (Age 55)
- Mr. Michael Mosticchio, Investor Relations
Who are Oaktree Specialty Lending's major shareholders?
Oaktree Specialty Lending's stock is owned by a number of of institutional and retail investors. Top institutional investors include Triad Investment Management (0.34%) and Confluence Investment Management LLC (0.23%). Company insiders that own Oaktree Specialty Lending stock include Bernard D Berman, Bruce Zimmerman, Craig A Jacobson, John Frank, Leonard M Tannenbaum, Marc Gamsin, Mathew Pendo, Melvin Carlisle, Oaktree Capital Management Lp and Richard Ruben. View Institutional Ownership Trends for Oaktree Specialty Lending.
Which major investors are buying Oaktree Specialty Lending stock?
OCSL stock was bought by a variety of institutional investors in the last quarter, including Triad Investment Management and Confluence Investment Management LLC. Company insiders that have bought Oaktree Specialty Lending stock in the last two years include Bruce Zimmerman, Craig A Jacobson, John Frank, Marc Gamsin, Mathew Pendo, Melvin Carlisle, Oaktree Capital Management Lp and Richard Ruben. View Insider Buying and Selling for Oaktree Specialty Lending.
How do I buy shares of Oaktree Specialty Lending?
Shares of OCSL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Oaktree Specialty Lending's stock price today?
One share of OCSL stock can currently be purchased for approximately $5.22.
How big of a company is Oaktree Specialty Lending?
Oaktree Specialty Lending has a market capitalization of $735.82 million and generates $138.72 million in revenue each year. The credit services provider earns $46.76 million in net income (profit) each year or $0.43 on an earnings per share basis.
What is Oaktree Specialty Lending's official website?
How can I contact Oaktree Specialty Lending?
Oaktree Specialty Lending's mailing address is 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071. The credit services provider can be reached via phone at 213-830-6300 or via email at [email protected]
MarketBeat Community Rating for Oaktree Specialty Lending (NASDAQ OCSL)
MarketBeat's community ratings are surveys of what our community members think about Oaktree Specialty Lending and other stocks. Vote "Outperform" if you believe OCSL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCSL will underperform the S&P 500 over the long term. You may vote once every thirty days.
